𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Skipping along: an exon skipping therapy shows promise for Duchenne muscular dystrophy

✍ Scribed by AK Hawkins


Book ID
110889309
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
511 KB
Volume
80
Category
Article
ISSN
0009-9163

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Theoretic applicability of antisense-med
✍ Annemieke Aartsma-Rus; Ivo Fokkema; Jan Verschuuren; Ieke Ginjaar; Judith van De πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 176 KB

Antisense-mediated exon skipping aiming for reading frame restoration is currently a promising therapeutic application for Duchenne muscular dystrophy (DMD). This approach is mutation specific, but as the majority of DMD patients have deletions that cluster in hotspot regions, the skipping of a smal

In vivo comparison of 2β€²-O-methyl phosph
✍ Hans A. Heemskerk; Christa L. de Winter; Sjef J. de Kimpe; Petra van Kuik-Romeij πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 409 KB

## Abstract ## Background Antisense‐mediated exon skipping is a putative treatment for Duchenne muscular dystrophy (DMD). Using antisense oligonucleotides (AONs), the disrupted DMD reading frame is restored, allowing generation of partially functional dystrophin and conversion of a severe Duchenne

Exon skipping and reading through stop c
✍ Guenter Scheuerbrandt πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 85 KB

## Exon skipping to change Duchenne into Becker dystrophy The exon-skipping technique tries to change a Duchenne into a Becker mutation. If a deletion or a point mutation disturbs the reading frame, and thus causes Duchenne dystrophy, the reading frame can be restored by removing one or more exons

In vitro evaluation of novel antisense o
✍ Qingsong Wang; HaiFang Yin; Patrizia Camelliti; Corinne Betts; Hong Moulton; Hyu πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 471 KB

## Abstract ## Background Targeted splice modulation of pre‐mRNA transcripts by antisense oligonucleotides (AOs) can correct the function of aberrant disease‐related genes. Duchenne muscular dystrophy (DMD) arises as a result of mutations that interrupt the open‐reading frame in the DMD gene encod